Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Digital Pathology Market: By Product Type, By Application, By Usage, By End-User and Region Forecast 2019-2030
Digital Pathology Market: By Product Type, By Application, By Usage, By End-User and Region Forecast 2019-2030
Digital pathology market size was valued at US$ 612.3 million in 2023 and is poised to grow at a CAGR of 12.7% from 2024-2030. Digital pathology is the practice of examining high-resolution digitally scanned histology images, which may subsequently be used with computer tools and algorithms. It is an image-based platform that allows pathology information to be acquired, managed, and interpreted from a digitized glass slide. Primary diagnosis, diagnostic consultation, intraoperative diagnosis, medical student and resident teaching, manual and semi-quantitative immunohistochemistry (IHC) evaluation, clinical research, diagnostic decision assistance, peer review, and tumor boards are all examples of healthcare uses.
After the FDA authorized the first entire slide scanner for use in primary diagnosis in April 2017, the market began to gather traction. Many pathology labs in the U.S. and Europe are switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. Scanners had a market worth of US$ 387.5 million in 2021, and it is expected to expand at a substantial CAGR between 2022 and 2028. The large share of the scanners segment can be attributed to the high price of scanners, the increasing adoption of digital pathology solutions, increase in R&D activities in the pharmaceutical & medical device industry, rise in demand for diagnosis of diseases, and surge in adoption of digital pathology systems. By Type segment, human pathology holds the market revenue share of 37.8% and it is estimated to grow with a significant CAGR from 2022 to 2028.
key companies featured in this digital pathalogy market research report are, Perkin Elmer Inc. (U.S.), Olympus Corporation (Japan), Spectra AB (Sweden), Philips Healthcare (U.S.), Danaher Corporation (U.S.), ZEISS Group (Germany), Roche Diagnostics (Germany), DigiPath Corp (U.S.), 3D-Histech Ltd (Hungary), GE Healthcare (U.S.), and more.
Study Period
2025-2031Base Year
2024CAGR
12.7%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
In the identification of pre-cancer and early cancer, where morphology is harder to interpret, pathologists are required to prepare more slides for each cancer specimen. This adds to the complexity of histopathological assessment, requiring more time from the pathologist. This raises a huge concern in the future regarding an unacceptable increase in turnover time. To avoid these issues, NHS U.K. recommends implementing digital pathology solutions in reference laboratories. NHS proposes that by 2020, 50% of patients referred for cancer testing by a GP will have their definitive diagnosis communicated to them within two weeks and 95% within four weeks.
The rise in cancer prevalence, the demand for accurate diagnostics, the rise in the geriatric population, and rapid technological advancements drive growth in the market. Moreover, the entry of established MedTech players into the market is seen as a validation of the concept that the technology can transform pathology. However, the high cost of digital pathology systems is hampering the market growth. The cost of digital pathology hardware, such as scanners, is significantly capital-intensive for diagnostic laboratories. Introducing low-cost scanners will encourage their adoption among pathologists with low or limited budgets.
North America digital pathology market holds the highest share (value terms) of 57% in 2023 and it is expected to grow at a significant rate in the coming years. The rising prevalence of cancer, rising demand for quality diagnostics, the implementation of favourable reimbursement policies, and the implementation of favourable initiatives by governments in the United States are major factors driving the growth of the market in North America.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2023 |
US$ 612.3 million |
|
Market CAGR |
12.7% |
|
By Product Type |
|
|
By Application |
|
|
By Usage |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The digital pathology market size was valued at US$ 612.3 million in 2023 and is projected to grow at a CAGR of 12.7% from2024-2030.
Increase in prevalence of cancers across the globe, demand for accurate diagnostics, implantation of artificial intelligence (AI) in digital pathology algorithms, quick turnaround time (TAT), rise in geriatric population are the key drivers for the market.
Digital Scanners accounts to hold major market share in the product segment.
The market is driven by the increasing prevalence of chronic diseases, the rising demand for faster diagnostic tools, and the focus on improving workflow efficiency in diagnostics
| 1. Executive Summary |
| 2. Global Digital Pathology Market Introduction |
| 2.1.Global Digital Pathology Market - Taxonomy |
| 2.2.Global Digital Pathology Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Application |
| 2.2.3.Usage |
| 2.2.4.End User |
| 2.2.5.Region |
| 3. Global Digital Pathology Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global Digital Pathology Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Digital Pathology Market By Product Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 5.1. Scanners |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Software solution/application |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Communication Systems |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Storage Systems |
| 5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Global Digital Pathology Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 6.1. Research & Academic |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Clinical Research & Toxicology |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Clinical Diagnostics |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Digital Pathology Market By Usage, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 7.1. Human Pathology |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Animal Pathology |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Global Digital Pathology Market By End User, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Reference Labs & Pathologists |
| 8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Pharmaceutical Companies |
| 8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Teaching & Research Institutes |
| 8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Others (vet, clinics etc.) |
| 8.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. Global Digital Pathology Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10. North America Digital Pathology Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Scanners |
| 10.1.2.Software solution/application |
| 10.1.3.Communication Systems |
| 10.1.4.Storage Systems |
| 10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Research & Academic |
| 10.2.2.Clinical Research & Toxicology |
| 10.2.3.Clinical Diagnostics |
| 10.3. Usage Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Human Pathology |
| 10.3.2.Animal Pathology |
| 10.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Reference Labs & Pathologists |
| 10.4.3.Pharmaceutical Companies |
| 10.4.4.Teaching & Research Institutes |
| 10.4.5.Others (vet, clinics etc.) |
| 10.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11. Europe Digital Pathology Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Scanners |
| 11.1.2.Software solution/application |
| 11.1.3.Communication Systems |
| 11.1.4.Storage Systems |
| 11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Research & Academic |
| 11.2.2.Clinical Research & Toxicology |
| 11.2.3.Clinical Diagnostics |
| 11.3. Usage Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Human Pathology |
| 11.3.2.Animal Pathology |
| 11.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Reference Labs & Pathologists |
| 11.4.3.Pharmaceutical Companies |
| 11.4.4.Teaching & Research Institutes |
| 11.4.5.Others (vet, clinics etc.) |
| 11.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 11.5.6.Rest of EU |
| 11.5.7. |
| 12. Asia Pacific (APAC) Digital Pathology Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Scanners |
| 12.1.2.Software solution/application |
| 12.1.3.Communication Systems |
| 12.1.4.Storage Systems |
| 12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Research & Academic |
| 12.2.2.Clinical Research & Toxicology |
| 12.2.3.Clinical Diagnostics |
| 12.3. Usage Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Human Pathology |
| 12.3.2.Animal Pathology |
| 12.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Reference Labs & Pathologists |
| 12.4.3.Pharmaceutical Companies |
| 12.4.4.Teaching & Research Institutes |
| 12.4.5.Others (vet, clinics etc.) |
| 12.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13. Middle East and Africa (MEA) Digital Pathology Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Scanners |
| 13.1.2.Software solution/application |
| 13.1.3.Communication Systems |
| 13.1.4.Storage Systems |
| 13.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Research & Academic |
| 13.2.2.Clinical Research & Toxicology |
| 13.2.3.Clinical Diagnostics |
| 13.3. Usage Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Human Pathology |
| 13.3.2.Animal Pathology |
| 13.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Reference Labs & Pathologists |
| 13.4.3.Pharmaceutical Companies |
| 13.4.4.Teaching & Research Institutes |
| 13.4.5.Others (vet, clinics etc.) |
| 13.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14. Latin America Digital Pathology Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Scanners |
| 14.1.2.Software solution/application |
| 14.1.3.Communication Systems |
| 14.1.4.Storage Systems |
| 14.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Research & Academic |
| 14.2.2.Clinical Research & Toxicology |
| 14.2.3.Clinical Diagnostics |
| 14.3. Usage Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Human Pathology |
| 14.3.2.Animal Pathology |
| 14.4. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Reference Labs & Pathologists |
| 14.4.3.Pharmaceutical Companies |
| 14.4.4.Teaching & Research Institutes |
| 14.4.5.Others (vet, clinics etc.) |
| 14.5. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Perkin Elmer Inc. (U.S.) |
| 15.2.2.Olympus Corporation (Japan) |
| 15.2.3.Spectra AB (Sweden) |
| 15.2.4.Philips Healthcare (U.S.) |
| 15.2.5.Danaher Corporation (Leica Microsystems) (U.S.) |
| 15.2.6.ZEISS Group (Germany) |
| 15.2.7.Roche Diagnostics (Germany) |
| 15.2.8.DigiPath Corp (U.S.) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.